Clinical trials
Suspended Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tsinghua Chang Gung Hospital | 1 |
| HRYZ Biotech Co. | 1 |
| Mirror Biologics, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Primocure Pharma | 1 |
| Roswell Park Cancer Institute | 1 |
| Rutgers, The State University of New Jersey | 1 |
| Shandong Cancer Hospital and Institute | 1 |
| St. Louis University | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 14 |
| Body Weight | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Digestive System Neoplasms | 1 |
| Fibrosis | 1 |
| Hepatitis C | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.